• Highly diluted candidate Ebola vaccine remains fully protective against disease in macaques

    27 days ago - By News Medical

    A single dose of a highly diluted VSV-Ebola virus vaccine-approximately one-millionth of what is in the vaccine being used to help control the ongoing Ebola outbreak in the Democratic Republic of the Congo -remains fully protective against disease in experimentally infected monkeys, according to National Institutes of Health scientists.
    Read more ...

     

  • EU Panel Gives Thumbs-Up on First Ebola Vaccine

    27 days ago - By Medscape

    The V920 Ebola Zaire vaccine protects against Ebola virus disease caused by Zaire Ebola virus in at-risk adults aged 18 years or older.
    International Approvals
    Read more ...